| Literature DB >> 32571284 |
Constanza San Martín Valenzuela1,2,3,4, Lirios Dueñas Moscardó2, Juan López-Pascual5, Pilar Serra-Añó6,7, José M Tomás8.
Abstract
BACKGROUND: In Parkinson's disease (PD) population, performing secondary tasks while walking further deteriorates gait and restrict mobility in functional contexts of daily life. This study (1) analyzed the interference of functional cognitive and motor secondary task on untrained people with PD and (2) compared their walking with healthy subjects.Entities:
Keywords: Biomechanical gait analysis; Functional dual-task; Kinematics; Kinetic; Parkinson’s disease
Mesh:
Year: 2020 PMID: 32571284 PMCID: PMC7310477 DOI: 10.1186/s12891-020-03431-x
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Clinical and demographical variables of participants
| PDG | HG | Between-groups | |||
|---|---|---|---|---|---|
| Range | Mean (SD) | Range | Mean (SD) | CI (95%) | |
| Age (years) | 44–79 | 66.72 (7.50) | 43–83 | 66.60 (8.75) | −2.98 to 4.69 |
| Weight (kg) | 43–99 | 70.45 (12.13) | 50–103 | 68.43 (12.15) | −6.24 to 4.97 |
| Height (m) | 1.44–1.76 | 1.61 (.07) | 1.42–1.82 | 1.58 (.08) | −.07 to .00 |
| BMI | 16.37–39.57 | 26.51 (4.63) | 21.93–38.77 | 27.22 (4.00) | −1.28 to 2.69 |
| Leg length (m) | 78–97 | 85.84 (4.52) | 73–99 | 85.34 (4.99) | −3.31 to 1.20 |
| Evolution (years) | 1–23 | 5.78 (4.67) | NP | NP | |
| Hoehn & Yahr scale | I:4 | 10 | NA | NA | – |
| II:9 | 22.5 | NA | NA | – | |
| III:27 | 67.5 | NA | NA | – | |
| Gender | Male: 17 | 42.5 | Male: 15 | 34.88 | .47 |
| Female: 23 | 57.5 | Female: 28 | 65.12 | ||
Main factors effects and their interactions on outcomes measures
| Outcomes | Condition | Group | Condition * Group |
|---|---|---|---|
| Velocity | |||
| Stride length | |||
| Cadence | |||
| Double support time | |||
| Ankle range | |||
| Hip extension | |||
| Hip flexion | |||
| Weight-acceptance force | |||
| Midstance force | |||
| Braking force |
Fig. 1Gait performance of both groups in all conditions of study. Mean and standard deviation represented with the vertical lines for the Parkinson’s disease group (PDG, dashed line) and the healthy group (HG, continuous line) for the Single-task (ST), visual (viDT), verbal (veDT), auditory (aDT) and motor (mDT) dual-task conditions. The upper horizontal black lines represent the statistical differences between single-task and dual-task conditions, while the differences between dual conditions are represented in blue. The letters below each horizontal line indicate statistically significant differences of the Parkinson’s disease group (a) and statistically significant differences of the healthy group (b)
Dual-task cost
| Outcomes | Condition to compare | PDG | HG | ||
|---|---|---|---|---|---|
| DT cost | 95% CI | DT cost | 95% CI | ||
| Velocity | Visual | −7.49 | −.04 to .19 | − 6.09 | −.04 to .18 |
| Verbal | −14.97 | .07 to .22* | −12.70 | .08 to .22* | |
| Auditory | −12.20 | .06 to .17* | −12.19 | .09 to .20* | |
| Motor | −15.09 | .08 to .20* | −10.34 | .06 to .18* | |
| Stride length | Visual | −6.19 | .01 to .14* | −4.95 | .01 to .13* |
| Verbal | −10.48 | .07 to .18* | −7.61 | .05 to .15* | |
| Auditory | −7.40 | .03 to .15* | −6.39 | .03 to .14* | |
| Motor | −13.0 | .08 to .25* | −6.74 | .01 to .18* | |
| Cadence | Visual | −.32 | −5.12 to 5.82 | −3.37 | −1.22 to 9.33 |
| Verbal | −4.33 | −1.12 to 10.73 | −6.19 | 1.73 to 13.16* | |
| Auditory | −2.07 | −4.06 to 8.65 | −5.72 | .75 to 13.01* | |
| Motor | −2.28 | −3.04 to 8.10 | −3.68 | −.94 to 9.80 | |
| Double support time | Visual | 7.16 | −3.39 to −.89* | 5.96 | −2.77 to −.36* |
| Verbal | 12.63 | −5.25 to −2.32* | 7.30 | −3.33 to −.50* | |
| Auditory | 7.70 | −3.28 to −1.32* | 8.56 | −3.19 to − 1.30* | |
| Motor | 10.66 | −4.57 to −1.81* | 9.19 | −3.74 to −1.08* | |
| Ankle range | Visual | −6.48 | .00 to 2.33* | −4.16 | −.29 to 1.95 |
| Verbal | −8.68 | .51 to 2.61* | −2.47 | −.51 to 1.50 | |
| Auditory | .45 | −1.66 to 1.50 | −.93 | −1.34 to 1.71 | |
| Motor | −11.24 | .59 to 3.46* | −.99 | −1.18 to 1.57 | |
| Hip extension | Visual | −5.70 | −2.07 to .98 | 3.01 | −1.19 to 1.75 |
| Verbal | −8.87 | −2.35 to .64 | .61 | −1.39 to 1.50 | |
| Auditory | −10.01 | −2.40 to .47 | −1.47 | − 1.52 to 1.25 | |
| Motor | −13.84 | −2.97 to .30 | − 2.37 | − 1.80 to 1.36 | |
| Hip flexion | Visual | −1.94 | −1.13 to 2.22 | −5.44 | .15 to 3.39* |
| Verbal | −5.15 | .17 to 2.69* | −5.66 | .62 to 3.05* | |
| Auditory | −2.23 | −.78 to 2.03 | −6.51 | .75 to 3.47* | |
| Motor | −4.37 | −.03 to 2.47 | − 6.71 | .97 to 3.39* | |
| Weight-acceptance force | Visual | −1.24 | −.19 to .39 | −2.55 | −.00 to .56 |
| Verbal | −1.20 | −.11 to .35 | −3.80 | .19 to .65* | |
| Auditory | −1.18 | −.13 to .38 | − 3.95 | .19 to .69* | |
| Motor | −.99 | −.17 to .39 | −2.42 | .01 to .56* | |
| Midstance force | Visual | 1.37 | −.34 to .09 | 2.42 | −.40 to .02 |
| Verbal | 4.16 | −.58 to −.11* | 6.09 | −.70 to −.24* | |
| Auditory | 2.91 | −.49 to −.01* | 7.02 | −.78 to −.31* | |
| Motor | 3.47 | −.54 to −.05* | 4.75 | −.63 to −.16* | |
| Braking force | Visual | −12.59 | −.24 to −.04* | − 10.03 | −.25 to −.05* |
| Verbal | −25.30 | −.42 to −.17* | − 11.96 | −.30 to −.06* | |
| Auditory | − 14.82 | −.29 to −.05* | − 16.67 | −.37 to −.14* | |
| Motor | − 17.59 | −.39 to −.04* | − 11.97 | −.36 to −.02* | |
Differences between single-task and dual-tasks conditions for each group from post-hoc analysis are shown with de 95% confidence interval (95% CI). * Indicates significant statistical differences between single-task and dual-task condition (p < .05). The dual-task cost was calculated with eq. 1. Negative percentages mean a decrease in the value measured during the dual-task compared with the single-task condition
Gait performance differences between groups
| Outcomes | Condition | PPgait% | 95% CI |
|---|---|---|---|
| Velocity | Single | −22.03 | .14 to .29* |
| Visual | −23.88 | .13 to .30* | |
| Verbal | − 25.29 | .13 to .29* | |
| Auditory | −22.04 | .11 to .27* | |
| Motor | −28.86 | .16 to .32* | |
| Stride length | Single | −12.60 | .1 to .25* |
| Visual | −14.09 | .1 to .26* | |
| Verbal | −16.21 | .12 to .27* | |
| Auditory | −13.82 | .1 to .25* | |
| Motor | −20.78 | .14 to .35* | |
| Cadence | Single | −8.48 | 5.44 to 13.36* |
| Visual | −5.16 | .85 to 12.25* | |
| Verbal | −6.37 | .1 to 13.24* | |
| Auditory | −4.43 | −2.1 to 11.72 | |
| Motor | − 6.92 | .83 to 14.18* | |
| Double support time | Single | 12.38 | −5.0 to −2.42* |
| Visual | 13.37 | −5.8 to −3.76* | |
| Verbal | 16.53 | −7.41 to −3.75* | |
| Auditory | 11.68 | −5.21 to −2.33* | |
| Motor | 13.55 | −6.26 to −2.73* | |
| Ankle range | Single | −10.62 | .23 to 3.60* |
| Visual | −13.36 | .54 to 4.00* | |
| Verbal | −18.13 | 1.4 to 4.60* | |
| Auditory | −9.10 | −.15 to 3.45 | |
| Motor | −23.38 | 2.24 to 5.25* | |
| Hip extension | Single | 2.84 | −1.88 to 2.42 |
| Visual | −6.13 | −2.18 to 1.10 | |
| Verbal | −7.27 | −2.32 to 1.05 | |
| Auditory | −6.39 | −2.21 to 1.11 | |
| Motor | −10.09 | −2.5 to .82 | |
| Hip flexion | Single | −16.49 | 1.4 to 7.80* |
| Visual | −12.33 | .32 to 6.43* | |
| Verbal | −15.86 | 1.35 to 7.05* | |
| Auditory | −11.39 | .24 to 6.00* | |
| Motor | −13.63 | .67 to 6.61* | |
| Weight-acceptance force | Single | −3.17 | .29 to 1.06* |
| Visual | −1.80 | .11 to .89* | |
| Verbal | −0.46 | .10 to .65* | |
| Auditory | −0.28 | .05 to .66* | |
| Motor | −1.68 | .28 to .77* | |
| Midstance force | Single | 11.66 | −1.09 to −.46* |
| Visual | 10.75 | −1.03 to −.39* | |
| Verbal | 10.03 | −.92 to −.39* | |
| Auditory | 8.13 | −.75 to −.21* | |
| Motor | 10.57 | −.96 to −.40* | |
| Braking force | Single | −25.66 | −.53 to −.18* |
| Visual | −29.35 | −.51 to −.17* | |
| Verbal | −48.10 | −.64 to −.29* | |
| Auditory | −22.93 | −.43 to −.12* | |
| Motor | −34.23 | −.50 to −.26* |
Differences between groups for each condition evaluated from post-hoc analysis are shown with the 95% confidence interval (95% CI). * Indicates significant statistical differences between groups (p < .05). PPgait: Performance of parkinsonian gait (%), negative values mean Parkinson’s disease group had registered lower values in the variable analyzed than the healthy group